Device / Technology News

RSS

New computer program to help young adults manage mental illness

While many young adults will share the details of their daily lives with dozens - sometimes hundreds - of friends on Facebook, communicating with their health care providers about mental illness is another story.

29 Sep 2010

ANDalyze sensor/Fluorimeter platform solution introduced in China and Australia

ANDalyze sensor/Fluorimeter platform solution for simplifying the on-site testing and analysis of water for heavy metal contamination is now being sold in China and Australia as a replacement to more time consuming testing methods such as electrochemical and reagent testing methods that require significant training.

29 Sep 2010

Cedars-Sinai physicians to lead St. Jude Medical's transcatheter aortic valve implantation clinical trial

St. Jude Medical, Inc., a global medical device company, today announced that physicians from the Cedars-Sinai Heart Institute will lead the company's transcatheter aortic valve implantation (TAVI) clinical trial. The study will evaluate the safety and efficacy of the St. Jude Medical transcatheter aortic valve for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery.

29 Sep 2010

Circulating tumor cells may be promising alternative for tumor biopsies

Circulating tumor cells (CTCs) may be a promising alternative, noninvasive source of tumor materials for biomarker assessment, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

29 Sep 2010

BAC completes feasibility study on CaptureSelect affinity ligands for Genmab

BAC BV, the leading provider of antibody-based affinity purification technology, today announced that it successfully completed a feasibility study in its collaboration with Genmab A/S (Copenhagen, Denmark), an international biotechnology company developing human antibody therapeutics for the potential treatment of cancer.

29 Sep 2010

Study analyses CT for screening of coronary artery calcification in radiation-induced cancer cases

A study based on computer modeling of radiation risk suggests that widespread screening for the buildup of calcium in the arteries using computed tomography scans would lead to an estimated 42 additional radiation-induced cancer cases per 100,000 men and 62 cases per 100,000 women, according to a report in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

29 Sep 2010

Study finds PEM scanners equivalent to breast MRI in detecting cancerous lesions

In a prospective study published in the European Journal of Nuclear Medicine and Molecular Imaging, researchers at Boca Raton Regional Hospital (Boca Raton, FL) showed that Positron Emission Mammography (PEM) and breast MRI had comparably high ability to detect cancerous lesions.

29 Sep 2010

Study shows Artelon scaffold improves cartilage repair outcome

A laboratory study (in vitro) and an animal study, which are currently being presented at the 9th World Congress of the International Cartilage Repair Society, demonstrate that Artelon functions as a scaffold for cells in conjunction with cartilage repair.

29 Sep 2010

New RTCA Cardio Instrument monitors real-time cardiomyocyte beating and cellular events

Roche announced today that it had launched the RTCA Cardio Instrument, the latest member of the xCELLigence product family. The RTCA Cardio Instrument is a medium throughput cell analyzer that utilizes impedance readings to monitor cardiac beating and cellular events in real time.

From Roche Sequencing and Life Science 29 Sep 2010

KINAXO, Daiichi Sankyo enter long-term partnership in cancer research

KINAXO Biotechnologies GmbH and Daiichi Sankyo Company Limited entered a long-term partnership in cancer research. Under the agreement, Daiichi Sankyo will employ KINAXO's technology platform to support the development of Daiichi Sankyo's targeted cancer drugs.

29 Sep 2010

Intrauterine devices for treatment of endometrial cancer

Intrauterine devices, originally developed as contraceptives, can also be used to treat and cure cancer of the endometrium according to new research published online in the cancer journal, Annals of Oncology today (Wednesday 29 September). The finding opens the way for young women with the disease, which affects the lining of the womb, to be treated without the need for a hysterectomy, thus preserving their fertility until they have had all the children they want.

29 Sep 2010

Pieris enters multi-year collaboration with Sanofi-Aventis and Sanofi Pasteur for Anticalin technology

Pieris AG announced today the signature of a collaboration and license agreement with both Sanofi-Aventis and Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, under which Pieris will apply its proprietary Anticalin technology to discover novel Anticalin drugs against multiple targets, with further development undertaken by Sanofi-Aventis and Sanofi-Pasteur. The collaboration will initially involve two targets nominated by Sanofi-Aventis and Sanofi-Pasteur, and includes the option for four additional targets.

29 Sep 2010

Generex Biotechnology receives new patent for buccal drug delivery system

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has been awarded a new patent in Canada.

29 Sep 2010

Covaris enters co-marketing partnership with Illumina for DNA shearing technologies

Covaris Inc. today announced that it has signed a co-marketing agreement with Illumina, Inc. making Covaris DNA shearing technologies the recommended method of shearing with Illumina next-generation sequencing product lines, including HiSeq, HiScanSQ, and Genome Analyzer.

From Illumina, Inc. 29 Sep 2010

New disposable, microfluidic PDMS device for identification of advanced breast cancer

A new disposable device based on advances in microfluidics may help identify advanced breast cancer patients who are candidates for therapy with the drug trastuzumab (Herceptin). The device is described in the American Institute of Physics' journal Biomicrofluidics.

29 Sep 2010

NIH grants Akonni $3M for development of multi-drug resistant/extensively drug-resistant genotyping test

Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated genetic testing devices for complex infectious and human diseases, today announced receipt of a nearly $3 million Challenge Grant from the National Institutes of Health (NIH), a new program made possible under the American Recovery and Reinvestment Act (ARRA).

29 Sep 2010

SCS, PNS prove to be effective tools in treating chronic pain: NANS, ASIPP

Afflicting countless people worldwide, chronic pain is a largely misunderstood and under-treated disease that forever alters the lives of more than 50 million Americans each year.

28 Sep 2010

USPTO issues Notice of Allowance for INSORB Skin Closure technology

Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for another key patent application, "Mechanical Method and Apparatus for Tissue Fastening." The allowed claims include subject matter covering the method of the INSORB Skin Closure technology and specific stapler features.

28 Sep 2010

ManagementPlus' EHR 5.0 software achieves CCHIT certification

On the heels of its pre market and ePrescribing conditional CCHIT certification, ManagementPlus' electronic health record software, ManagementPlus EHR 5.0, has now achieved full certification for its product, CCHIT Certified 2011 Ambulatory EHR.

28 Sep 2010

Intellidose expert to moderate a panel of EMR champions at ACCC

The economics of private oncology practices have fundamentally changed in the past three years - driving practice consolidation, specialty diversification, and hospital affiliations. While dealing with these external pressures, oncology practices also need to automate key practice processes with technology - and plan that investment wisely in expectation of continued change.

28 Sep 2010

Device / Technology News

New computer program to help young adults manage mental illness

ANDalyze sensor/Fluorimeter platform solution introduced in China and Australia

Cedars-Sinai physicians to lead St. Jude Medical's transcatheter aortic valve implantation clinical trial

Circulating tumor cells may be promising alternative for tumor biopsies

BAC completes feasibility study on CaptureSelect affinity ligands for Genmab

Study analyses CT for screening of coronary artery calcification in radiation-induced cancer cases

Study finds PEM scanners equivalent to breast MRI in detecting cancerous lesions

Study shows Artelon scaffold improves cartilage repair outcome

New RTCA Cardio Instrument monitors real-time cardiomyocyte beating and cellular events

KINAXO, Daiichi Sankyo enter long-term partnership in cancer research

Intrauterine devices for treatment of endometrial cancer

Pieris enters multi-year collaboration with Sanofi-Aventis and Sanofi Pasteur for Anticalin technology

Generex Biotechnology receives new patent for buccal drug delivery system

Covaris enters co-marketing partnership with Illumina for DNA shearing technologies

New disposable, microfluidic PDMS device for identification of advanced breast cancer

NIH grants Akonni $3M for development of multi-drug resistant/extensively drug-resistant genotyping test

SCS, PNS prove to be effective tools in treating chronic pain: NANS, ASIPP

USPTO issues Notice of Allowance for INSORB Skin Closure technology

ManagementPlus' EHR 5.0 software achieves CCHIT certification

Intellidose expert to moderate a panel of EMR champions at ACCC

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News